It Works!

Colloidal Silver kills COVID-19 and the vast majority of harmful viruses and bacteria in 5 minutes! Science has proved and published it.

As with anything, there are passionate arguments for and against colloidal silver and like politics, it is difficult to tell who speaks the truth, who has the better good at heart and who has personal interests involved. Usually arguments against it are made by those who have financial interests involved and there is not a lot of money in colloidal silver compared to pharmaceuticals.

We use it, we make it and we sell it; but we highly recommend that everyone make their own – that way you KNOW exactly what is in it! Either way, we want you to try it and judge for yourself.

The NCBI is part of the United States National Library of Medicine, a branch of the National Institute of Health.   They published a study that found that silver nano particles kill COVID-19.

Potent antiviral effect of silver nanoparticles on SARS-CoV-2 

Sundararaj S. Jeremiah, Kei Miyakawa, […], and Akihide Ryo 

This is a summary of excerpts from an article published in the NCBI (National Center for Biotechnology Information). The NCBI is part of the United States National Library of Medicine, a branch of the National Institute of Health.   

The full article is available for all to see. Just follow this link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486059/

Excerpts  

…particles of diameter around 10 nm were effective in inhibiting extracellular SARS-CoV-2 at concentrations ranging between 1 and 10 ppm while cytotoxic effect was observed at concentrations of 20 ppm and above. 

The elemental metal, Silver (Ag) has broad spectrum antimicrobial action against various bacteria, fungi and viruses. 

Several studies have demonstrated the potent antiviral action of AgNPs (silver nano particles) against various human pathogenic viruses such as Respiratory syncytial virus (RSV), Influenza virus, Norovirus, Hepatitis B virus (HBV) and Human immunodeficiency virus (HIV).  In addition to these viruses, since Ag has been demonstrated to kill SARS-CoV, 

RESULTS 

after 96 h cAg showed robust antiviral effect denoted by increased viability of infected VeroE6/TMPRSS2 cells at concentrations ranging between 1 and 10 ppm. In Calu-3 cells, significant viral load reduction was observed at similar cAg (colloidal silver) concentration range 

Ag was found to exhibit cytotoxicity at concentrations from 20 parts per million (ppm) onward. 

Previous studies have documented the size dependent potency of AgNPs in viral inactivation, with ≤10 nm particle size reported to have maximum antiviral effect  

Antiviral effect was noted with AgNPs of size ranging from 2 to 15 nm  

Silver inhibits extracellular viruses by preventing viral entry the infected cells were treated with 2 ppm of PVP-AgNP10. We observed significant protection of infected cells and suppression of viral load with PVP-AgNP10 (silver nano particles 10nm diameter). 

Several studies have reiterated the size dependent antiviral effect of AgNPs with particles around 10 nm diameter being most effective. This has been attributed the higher stability of interaction to the viral protein achieved by 10 nm particles which is not capable by larger particles. Consistent with this, we also observed anti-SARS-CoV-2 activity only with AgNPs of diameters ranging from 2 to 15 nm. Our immunofluorescence study corroborated the above phenomenon, as we observed that PVP-AgNP10 completely inhibited SARS-CoV-2  

Antiviral effect of AgNPs is also concentration dependent. Most studies have observed the antiviral efficacy of AgNPs at concentrations ranging between 10 and 100 ppm [1]. However, 0.5 ppm cAg has been shown effective in inhibiting Influenza virus and is the least concentration that has been reported to show antiviral activity [20]. In the current study, we observed naked AgNPs to inhibit SARS-CoV-2 at concentrations ranging between 1 and 10 ppm and become cytotoxic to mammalian cells from 20 ppm and above. 

Ag is a very broad spectrum microbicide.  AgNPs can be used on a variety of inanimate surfaces to combat the ongoing COVID-19 pandemic. Ag coated masks have been found to be effective in inhibiting SARS-CoV-2 and could potentially be effective when applied on the air filters of air conditioners and medical devices [25]. AgNP incorporated polycotton fabrics have been proven to inhibit SARS-CoV-2 [26]. Ag based sanitizers and disinfectants are also being used for disinfection of hands and inanimate surfaces respectively. 

BYU Microbiology Dept Report

Brigham Young University is a world renowned institution of higher learning and in 1999 the Microbiology Department published the following after testing a colloidal silver solutrion. The results speak for themself:

BACTERIA TESTING
Microbiology Department
Brigham Young University
775 WIDB
P.O. Box 25253
Provo, Utah 84602-5253

May 13, 1999

…Silver Supplement has been tested against the following organisms.

Staphylococcus aureus (Pneumonia, eye infections, skin infections (boils, impetigo, cellulitis, and post-operative wound infections), toxic shock syndrome, meningitis, food poisoning, osteomyelitis, and many others) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/22/99 BYU Report.

Shigella boydii (Bacillary dysentery–characterized by severe cramping abdominal pain and bloody diarrhea) inhibited @ 1.25 ppm and killed @ 2.5 ppm. 1/22/99 BYU Report.

Salmonella arizona (Food poisoning, etc.) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/28/99 BYU Report.

Salmonella typhimurium (Food poisoning and enteric fever) inhibited and killed at a concentration of 2.5 ppm. 6/7/99 BYU Report.

E. coli (Food poisoning, urinary tract infections, traveler’s diarrhea, diarrhea in infants, respiratory tract infections, and wound infections) inhibited and killed @ 2.5 ppm. 1/22/99 BYU Report.

Haemophilus influenzae (Otitis media (ear infection), pneumonia, meningitis, throat and sinus infections (including epiglottitis in children and sinusitis), and suppurative arthritis in children) inhibited and killed @ 1.25 ppm. 1/22/99 BYU Report.

Enterobacter aerogenes ( wound infections, urinary tract infections, bacteremia, and meningitis) inhibited and killed at a concentration of 2.5 ppm. 6/7/99 BYU Report.

Enterobacter cloacae ( causes ilnesses similar to the E. aerogenes) inhibited and killed at a concentration of 5 ppm. 6/7/99 BYU Report.

Klebsiella pneumoniae (lower respiratory tract infections, nosocomial infections (infections spread in hospitals), urinary tract and wound infections, and bacteremia) inhibited and killed @ 2.5 ppm. 1/28/99 BYU Report.

Klebsiella oxytoca (Similar to those infections caused by K. pneumoniae) inhibited and killed at a concentration of 2.5 ppm. 6/7/99BYU Report.

Pseudomonas aeruginosa (severe burn and wound infections, keratitis, pneumonia, meningitis, nosocomial infections, urinary tract infections, etc.) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/22/99 BYU Report.

Streptococcus pneumoniae (pneumonia, meningitis, sinusitis, otitis media (ear infection) inhibited @ 2.5 ppm and killed @ 5 ppm. 4/21/99 BYU Report.

Streptococcus pyogenes (skin infections, upper respiratory infections (i.e. strep throat) impetigo, hospital-acquired infections, scarlet fever, etc.) inhibited and killed @ 1.25 ppm. 1/22/99 BYU Report.

Streptococcus faecalis (Urinary tract infections, endocarditis, wound infections, etc.) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/22/99 BYU Report.\

Streptococcus mutans (A major cause dental plaque and tooth decay etc.) inhibited and killed @ 5 ppm. 2/3/99 BYU Report.

Streptococcus gordonii (Tooth decay, also implicated in infective endocarditis-an infection of the heart valves) inhibited and killed @ 5 ppm. BYU Report 2/12/99.\

David A. Revelli
Microbiologist
Brigham Young University
Dr. Ron W. Leavitt, Ph.D.
Professor of Microbiology/Molecular Biology